Home Healthcare Medical Devices Butterfly Needle Sets Market

Butterfly Needle Sets Market Size, Share & Trends Analysis Report By Applications (Blood transfusion, Venipuncture, IV Rehydration, Delivery of medications), By End-User (Hospitals, Blood banks, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Butterfly Needle Sets Market Size

The global butterfly needle sets market size was valued at USD 304.46 million in 2025 and is projected to grow from USD 329.73 million in 2026 to USD 624.00 million by 2034, registering a CAGR of 8.3% during the forecast period from 2026 to 2034. Asia Pacific dominated the butterfly needle sets market with a market share of 37.6% in 2025.

Winged infusion sets and scalp vein sets are additional names for butterfly needle sets. These sets are utilized for IV rehydration, drug infusions, and blood extraction from veins. Butterfly needles are used more frequently for blood transfusions than alternative items because they are less expensive, more efficient, and less painful than those alternatives. Butterfly needles provide advantages over straight needles, including the ability to be placed more precisely, especially in difficult-to-access veins. A hypodermic needle, two flexible wings on either side, and a connector are all included in butterfly needle sets, which take blood from an infusion pump using a vacuum tube or collecting bag.

Butterfly Needle Sets Market Size

Download a Free Sample To learn more about this report.

Application Insights

The global market is bifurcated into blood transfusion, venipuncture, IV rehydration, and delivery of medications. The blood transfusion segment is the highest contributor to the market and is expected to grow at a CAGR of 8.7% during the forecast period. Giving a sick patient an intravenous blood transfusion involves giving healthy people blood or blood products like platelets, albumin, cryoprecipitate, and plasma. Patients with bleeding disorders like hemophilia or von Willebrand disease benefit from the butterfly needle. Large-sized butterfly needle gauges with vacuum systems are needed to collect blood for transfusions. Additionally, numerous combinations of butterfly needles for blood transfusion are available, including single-use/disposable, sterile, and winged needles attached to flexible tubing with a luer connector.

Several businesses, including SOL-Millennium, Zibo Econst Medical Instrument Co., Ltd, Perfect Medical Industry Co., Ltd., and Smiths Medical, also provide butterfly needles on a global scale. A study published in Academic Emergency Medicine in 2016 found that drawing blood with butterfly needles reduced the rate of red blood cell destruction by half compared to drawing blood with IV catheter needles. Therefore, these factors contribute to the market's growth.

The venipuncture procedure is used to gain intravenous access for blood sampling or intravenous therapy. A winged infusion set, also referred to as a butterfly or scalp vein set, is a tool used in venipuncture for phlebotomy, the procedure of inserting a cannula into a vein to puncture it to draw blood. Phlebotomists, medical professionals who specialize in drawing blood, draw blood primarily by performing venipunctures, but they can also draw blood with butterfly needles. A hypodermic needle, two flexible bilateral wings, and flexible small-bore transparent tubing with 21G (gauge) or smaller needles are required for the venipuncture procedure. The flexible tubing in the butterfly wings allows flexibility to reach various body surfaces. It offers patient movement tolerance, making venipuncture of the hand and leg's superficial veins easier. Additionally, venipuncture is the preferred technique for drawing blood from newborns because it is quicker, less painful, and associated with less anxiety in the mother.

Butterfly Needle Sets Market Size By Segments

Request Customizationto receive a tailored report.

End-User Insights

The global market is bifurcated into hospitals and blood banks. The hospital segment owns the highest market share and is anticipated to grow at a CAGR of 8.3% during the forecast period. A hospital is a place of health care that offers patient care using specialized medical and nursing staff and medical supplies. To collect blood for diagnostic tests like the complete blood count (CBC), cholesterol tests, diabetes monitoring, and STD screening, pathology departments in hospitals use butterfly needles to prick the patients' veins. Additionally, because butterfly needles are flexible, thin, and painless, they are preferred during surgery for patients with cancer, HIV, and hemophilia. They are in critical care, intravascular treatments, and cardiovascular surgeries.

A blood bank is a location where people can donate blood and have their blood collected, stored, and used to help those in need. People who want to donate blood frequently use butterfly needles at blood banks, especially those whose veins are small and spastic. The American Association of Blood Banks (AABB) Standards in 2014 for Blood Banks and Transfusion Services also state that platelet apheresis donor blood can only be drawn 24 times in a rolling 12-month period, or a maximum of two times per week. There should be at least two days between the two collections. To prevent excessive donor platelet and plasma loss, the Food and Drug Administration (FDA) mandated these guidelines for the industry. However, new regulations enable donors to give blood more frequently. According to the American National Red Cross, 6.8 million Americans donate blood annually.

Butterfly Needle Sets Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

Asia-Pacific is the most significant contributor to the global butterfly needle sets market and is expected to grow at a CAGR of 9.4% during the forecast period. India, China, Japan, Australia, South Korea, and the rest of Asia-Pacific are among the nations represented in the Asia-Pacific market. The butterfly needle set market is the largest and quickly expanding in the Asia-Pacific region. Due to the vast untapped potential in this area, it is the most lucrative market. It is anticipated that the rising purchasing power of populous nations like China and Japan will accelerate the expansion of the Asia-Pacific market. In addition, factors like the rise in blood donation clinics in this region due to population growth and the development of the Thalassemic, Hemophilic, and cancer patient pools contribute to the market's expansion. Furthermore, the market growth is anticipated to be fueled by significant key players like B. Braun Melsungen AG, ISOMed, BioMatrix S.r.l., Nipro Corporation, and Kawasumi Laboratories, Inc.

Asia Pacific Butterfly Needle Sets Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

North America Butterfly Needle Sets Market Trends

North America is expected to grow at a CAGR of 7.80% during the forecast period. In 2021, North America was the second-highest revenue-producing region. The most common chronic diseases for which butterfly needles are used are bleeding disorders and cancer. The U.S. leads the market for butterfly needle sets in North America, followed by Canada. In addition, leading U.S. industry participants like Becton, Dickinson and Company, Cardinal Health, Inc., Greiner Bio-One North America, Inc., Medline Industries, Inc., JMS North America Corporation, and Terumo Corporation are responsible for the. In 2018, 17,757 Americans received a hemophilia diagnosis. A genetic blood disorder called hemophilia impairs blood clotting's normal functionality. The market for butterfly needle sets is also growing due to blood collection regulations and clinical trial usage.

Europe Butterfly Needle Sets Market Trends

Europe is expected to grow significantly over the forecast period. The market for butterfly needle sets in Europe is anticipated to grow due to increasing attention paid to hemolysis in clinical trials and an increase in chronic diseases. More than one million needle stick injuries occur annually in Europe, which prompted the establishment of government regulations to decrease these injuries in 2013. Additionally, newborns are being treated for symptomatic pneumothorax with needle aspiration (NA) and chest drain (CD) insertion, thanks to clinical trials conducted in 2018 in European neonatal intensive care units on newborns. Thus, the above factors contribute to the market's expansion.

Brazil, South Africa, Saudi Arabia, and the rest of LAMEA are among the nations considered in this region. The butterfly needle sets market is the least active in LAMEA. However, the market is anticipated to grow due to untapped opportunities, such as many people with chronic diseases, the aging population, and inadequate healthcare facilities. Due to the rising geriatric population and the high prevalence of chronic diseases that necessitate butterfly needles in this area, penetration of butterfly needles is anticipated to experience steady demand in the future. As a result, the market for butterfly needle sets is expected to grow due to the rise in the number of people who require them.

List of Key and Emerging Players in Butterfly Needle Sets Market

B. Braun Melsungen Ag
Becton
Dickinson and Company
Nipro Corporation (Nipro Medical Corporation)
Cardinal Health Inc
Medline Industries, Inc
Terumo Corporation (Terumo Medical Corporation)
Kawasusr Laboratories, Inc. (Kawasusr Laboratories America, Inc.)
Isomed
Biomatrix S.R.L
Smith’s Group Plc

Key Industry Developments

January 2026
BD (Becton, Dickinson and Company) expanded its vascular access product portfolio with continued advancements in safety needle technologies and blood collection solutions. The company focused on improving clinician usability, patient comfort, and infection prevention across venipuncture procedures.
November 2025
Terumo Corporation expanded its blood collection and vascular access product portfolio with enhancements to needle-based medical devices designed for improved safety and ease of use. The company continued developing minimally invasive solutions for healthcare providers.
September 2025
Nipro Corporation expanded its medical device portfolio with continued development of needle and blood collection products, including safety-focused solutions for hospitals, laboratories, and outpatient care settings.
August 2025
Greiner Bio-One expanded its preanalytical healthcare solutions portfolio with improvements in blood collection systems and accessories. The company continued strengthening its venous blood collection offerings through product innovation and laboratory workflow solutions.

Report Scope

Segmentation

By Applications 4
  • Blood transfusion
  • Venipuncture
  • IV Rehydration
  • Delivery of medications
By End-User 3
  • Hospitals
  • Blood banks
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage B. Braun Melsungen Ag · Becton · Dickinson and Company · Nipro Corporation (Nipro Medical Corporation) · Cardinal Health Inc
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The butterfly needle sets market size is valued at USD 329.73 Million in 2026 and is projected to reach USD 624.00 Million by 2034, at a CAGR of 8.3% during the forecast period 2026-2034.
Asia Pacific dominated the market with a share of 37.6% in 2025.
The leading players in this market are B. Braun Melsungen Ag, Becton, Dickinson and Company, Nipro Corporation, Cardinal Health Inc.
The butterfly needle sets market is projected to grow at a CAGR of 8.3% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now